Improving Insulin Sensitivity by Non-invasive Brain Stimulation

Sponsor
University Hospital Tuebingen (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04420650
Collaborator
German Center for Diabetes Research (Other)
48
1
3
24.2
2

Study Details

Study Description

Brief Summary

Efforts in curing and preventing obesity and type 2 diabetes (T2D) have been elusive thus far. One reason for that is the lack of understanding of the role of the brain in the development and treatment of the disease. In recent studies, the hypothalamus was identified as part of a brain network including higher cognitive regions that is particularly vulnerable to insulin resistance. Furthermore, the central insulin response in this network predicted food craving and hunger. In this project, transcranial direct current stimulation (tDCS) is implemented as a tool to stimulate brain networks. The investigators hypothesize that stimulating the hypothalamus-cognitive network will enhance insulin sensitivity and reduce food intake, food craving and hunger. Furthermore, the project will provide the unique opportunity to investigate novel mechanisms of insulin resistance in participants who have been extensively metabolically characterized.

Condition or Disease Intervention/Treatment Phase
  • Device: transcranial direct current stimulation
N/A

Detailed Description

Objectives The overarching aim of the study is to stimulate the hypothalamus-cognitive brain network to improve insulin sensitivity and eating behavior.

Specific Objectives

  1. Implement tDCS stimulation compared to sham stimulation in overweight and obese adults to assess the impact on eating behavior, cognition and metabolism.

  2. Evaluate whether 3-day non-invasive brain stimulation of the hypothalamus-cognitive network has a causal effect on metabolism.

  3. Evaluate whether 3-day non-invasive brain stimulation has a significant effect on brain functional connectivity and diffusion parameters.

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Official Title:
Improving Insulin Sensitivity by Non-invasive Brain Stimulation
Actual Study Start Date :
May 26, 2020
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Anodal tDCS

Anodal tDCS of the hypothalamus-cognitive network

Device: transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation

Active Comparator: Cathodal tDCS

Cathodal tDCS of the hypothalamus-cognitive network

Device: transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation

Sham Comparator: Sham Stimulation

Single blind sham stimulation (ramp-up ramp-down stimulation will be applied for 30 seconds in order to simulate the active condition without any further continuous administration of current)

Device: transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation

Outcome Measures

Primary Outcome Measures

  1. Peripheral insulin sensitivity [1 day after last intervention tDCS day]

    Oral glucose tolerance derived insulin sensitivity based on the Matsuda index

  2. Caloric intake (kcal) [1 hour directly after tDCS stimulation]

    Free-choice, ad libitum food intake from a standardized breakfast buffet. The caloric intake from fat, carbohydrates and protein will be documented.

  3. Change in subjective feeling of hunger and food craving [5 minutes before tDCS stimulation, 5 minutes after tDCS stimulation and 5 minutes after buffet]

    On a visual analogue scale, subjective feeling of hunger and food craving will be assessed using a questionnaire.

Secondary Outcome Measures

  1. Performance during stop-signal task [task is performed during 20-minutes tDCS stimulation]

    Outcome measures cover direction errors, proportion of successful stops, reaction time on Go trials, and stop signal reaction time (SSRT).

  2. Tastiness and healthiness rating of food stimuli [task is performed immediatly after buffet]

    Using a computer based task, participants rate food pictures of low caloric and high caloric foods and snacks on a 5-point scale based on subjective tastiness and healthiness.

  3. Food choice [task is performed immediatly after buffet]

    Using a computer based task, participants have to choose food items they preferred to eat compared to a reference food on a 5-point choice scale. The reference (or "neutral") food item is individually determined based the health and taste rating [Scale: 1= not tasty/ not healthy up to 5= very tasty/ very heahlty].

  4. Functional connectivity [10 minutes functional MRI measurement performed before and after three day tDCS stimulation]

    Resting-state functional connectivity of the hypothalamus-cognitive network is assessed by functional magnetic resonance imaging (fMRI)

  5. Diffusion-weighted imaging [15 minutes MRI measurement performed before and after three day tDCS stimulation]

    Diffusion weighted parameter based on MRI measurements

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 66 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Body mass index (BMI) between 25.5 and 39.5 kg/m2

  • Age between 20 to 66 years of age

  • Waist circumference > 80 cm for women, > 94 cm for men

Exclusion Criteria:
  • Insufficient knowledge of the German language

  • Persons who cannot legally give consent

  • Pregnancy or lactation

  • History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures)

  • Taking psychotropic drugs

  • Previous bariatric surgery

  • Acute infection within the last 4 weeks

  • Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men

  • Current participation in a lifestyle intervention study or a pharmaceutical study

  • Contradictions to a MRI measurement (e.g. metal implants)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Clinic Tübingen Tübingen Germany 72076

Sponsors and Collaborators

  • University Hospital Tuebingen
  • German Center for Diabetes Research

Investigators

  • Principal Investigator: Stephanie Kullmann, PhD, Univeristy of Tübingen, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT04420650
Other Study ID Numbers:
  • BRAINSTIM
First Posted:
Jun 9, 2020
Last Update Posted:
Sep 29, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2021